Greenwich LifeSciences In...

NASDAQ: GLSI · Real-Time Price · USD
12.11
0.03 (0.25%)
At close: Aug 15, 2025, 3:59 PM
12.17
0.50%
After-hours: Aug 15, 2025, 04:10 PM EDT

Greenwich LifeSciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
4.09M 6.99M 13.47M 27.2M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a 0.00 n/a
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
n/a n/a n/a n/a
Total Current Assets
4.09M 6.99M 13.47M 27.2M
Property-Plant & Equipment
n/a n/a n/a n/a
Goodwill & Intangibles
1.78K 5.39K 9K 12.62K
Total Long-Term Assets
1.78K 5.39K 9K 12.62K
Total Assets
4.09M 6.99M 13.48M 27.22M
Account Payables
1.18M 35.47K 220.84K 220.84K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
382.2K n/a n/a n/a
Total Current Liabilities
1.56M 294.41K 262.9K 385.17K
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
n/a n/a 220.84 n/a
Total Liabilities
1.56M 294.41K 262.9K 385.17K
Total Debt
n/a n/a n/a n/a
Common Stock
13.15K 12.85K 12.85K 13.15K
Retained Earnings
-66.15M -50.36M -41.47M -33.65M
Comprehensive Income
n/a 0.00 n/a -0.00
Shareholders Equity
2.53M 6.7M 13.21M 26.83M
Total Investments
n/a n/a n/a n/a